FDA guideline on BE, draft August 2021 [BE/BA News]

posted by Helmut Homepage – Vienna, Austria, 2021-08-23 23:46 (308 d 05:25 ago) – Posting: # 22535
Views: 1,830

Hi Achievwin,

» FDA decided to split BA/BE guidance into two guidance 1) for ANDA filings and 2) for IND/NDAs

Already in 2013/2014.

» More elaborate explanations of each aspect.

I expect to see an update of #2 (current draft of Feb 2019) as well.

Dif-tor heh smusma 🖖 [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,178 posts in 4,646 threads, 1,571 registered users;
online 8 (0 registered, 8 guests [including 2 identified bots]).
Forum time: Tuesday 05:11 CEST (Europe/Vienna)

It is futile to do with more things
that which can be done with fewer.    William of Ockham

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5